Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Villoslada P, Vila G, Colafrancesco V, Moreno B, Fernandez-Diez B, Vazquez R, Pertsovskaya I, Zubizarreta I, Pulido-Valdeolivas I, Messeguer J, Vendrell-Navarro G, Frade JM, López-Sánchez N, Teixido M, Giralt E, Masso M, Dugas JC, Leonoudakis D, Lariosa-Willingham KD, Steinman L, Messeguer A.

Neurotherapeutics. 2019 Jul;16(3):808-827. doi: 10.1007/s13311-019-00717-4.

PMID:
30815844
2.

NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes.

Mantelli F, Lambiase A, Colafrancesco V, Rocco ML, Macchi I, Aloe L.

Eur J Ophthalmol. 2014 Mar-Apr;24(2):247-53. doi: 10.5301/ejo.5000359. Epub 2013 Sep 5.

PMID:
24030532
3.

Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration.

Colafrancesco V, Coassin M, Rossi S, Aloe L.

Ann Ist Super Sanita. 2011;47(3):284-9. doi: 10.4415/ANN_11_03_08.

4.

Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases.

Colafrancesco V, Villoslada P.

Arch Ital Biol. 2011 Jun;149(2):183-92. doi: 10.4449/aib.v149i2.1376. Review.

PMID:
21701990
5.

Nerve growth factor in the developing and adult lacrimal glands of rat with and without inherited retinitis pigmentosa.

Muzi S, Colafrancesco V, Sornelli F, Mantelli F, Lambiase A, Aloe L.

Cornea. 2010 Oct;29(10):1163-8. doi: 10.1097/ICO.0b013e3181d3d3f9.

PMID:
20595895
6.

Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma.

Colafrancesco V, Parisi V, Sposato V, Rossi S, Russo MA, Coassin M, Lambiase A, Aloe L.

J Glaucoma. 2011 Feb;20(2):100-8. doi: 10.1097/IJG.0b013e3181d787e5.

PMID:
20436364
7.

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.

Lambiase A, Aloe L, Centofanti M, Parisi V, Báo SN, Mantelli F, Colafrancesco V, Manni GL, Bucci MG, Bonini S, Levi-Montalcini R.

Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13469-74. doi: 10.1073/pnas.0906678106.

8.

Anti-NGF-antibody administration as collyrium reduces the presence of NGF and enhances the expression of VEGF in the retina, lacrimal gland and hippocampus.

Colafrancesco V, Cirulli F, Rossi S, Berry A, Aloe L.

Neurosci Lett. 2009 Oct 9;463(3):203-6. doi: 10.1016/j.neulet.2009.07.082. Epub 2009 Aug 3.

PMID:
19651190
9.

Insulin-like growth factor-1 inhibits STS-induced cell death and increases functional recovery of in vitro differentiated neurons.

Pucci B, Bertani FR, Indelicato M, Sale P, Lococo E, Grassi F, Pagani F, Colafrancesco V, Morgante E, Tafani M, Fini M, Russo MA.

Cell Cycle. 2008 Dec 15;7(24):3869-77. Epub 2008 Dec 27.

PMID:
19098425
10.

Supplemental Content

Loading ...
Support Center